Adage Capital Partners’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100,000
Closed -$1.77M 968
2025
Q1
$1.77M Buy
+100,000
New +$3.26M ﹤0.01% 768
2020
Q2
Sell
-4,167
Closed -$778K 805
2020
Q1
$778K Sell
4,167
-33,333
-89% -$7.85M ﹤0.01% 690
2019
Q4
$9.06M Hold
37,500
0.02% 552
2019
Q3
$6.35M Buy
+37,500
New +$8.49M 0.02% 593
2018
Q4
Sell
-7,917
Closed -$4.93M 766
2018
Q3
$4.93M Sell
7,917
-21,250
-73% -$9.42M 0.01% 639
2018
Q2
$10M Buy
+29,167
New +$10.5M 0.02% 565

Other funds holding TECX

Adage Capital Partners's TECX Position: Q2 2025 in Review

Adage Capital Partners sold out of Tectonic Therapeutic (TECX) in Q2 2025, closing a stake of 100,000 shares — an estimated $1.77M sold.

Adage Capital Partners first reported a position in TECX in Q2 2018 and held it in 6 quarters. The position peaked at $10M in Q2 2018. 82 funds tracked by Wall St. Rank hold TECX as of Q2 2025.

  • Adage Capital Partners reported no remaining Tectonic Therapeutic position as of Q2 2025 after selling out during the quarter.
  • Adage Capital Partners sold 100,000 Tectonic Therapeutic shares in Q2 2025, an estimated $1.77M.
  • Adage Capital Partners first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 6 quarters.
  • Adage Capital Partners's Tectonic Therapeutic position peaked at $10M in Q2 2018.
  • 82 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2025.

Based on Adage Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.